Lipid Disorder Treatment Market - Global Industry Analysis
Lipid Disorder Treatment Market: by Drug Type (Pravastatin, Simvastatin, Rosuvastatin, Fluvastatin, Atorvastatin and Other Drugs); by Indication (Heterozygous Familial Hypercholesterolemia, Familial Hypertriglyceridemia, Familial Dysbetalipoproteinemia, Familial Defective Apolipoprotein B-100, Familial Combined Hyperlipidemia and Other Indications); by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025
Published Date: 13-Nov-2019Healthcare
Category: Report Format : PDF
Report Code: ZMR-5043
Status : Published
According to the report, global demand for lipid disorder treatment market was valued at approximately USD 22.42 billion in 2018, and is expected to generate revenue of around USD 38.04 billion by end of 2025, growing at a CAGR of around 7.9% between 2019 and 2025.